MARATTO

article · Records of Pharmaceutical and Biomedical Sciences/Records of Pharmaceutical & Biomedical Sciences

Green Spectrophotometric Method for the Determination of Tigecycline in Different Matrices

Abstract

This work presents a green, simple, validated colorimetric method for the determination of tigecycline in lyophilized powder and laboratory prepared pharmaceutical wastewater. The suggested method depends on the reaction of tigecycline with Eosin-Y targeting its tertiary amino group, forming a reddish-orange ion pair complex with a wavelength of maximum absorbance of 555 nm. The greenness of this method was assessed by four methods; 1-National Environmental Methods Index assessment (NEMI), 2-Analytical Eco-Scale assessment, 3-Green Analytical Procedure Index assessment (GAPI), and 4-The Analytical Greenness Metric assessment (AGREE). They showed the significant greenness of the proposed method. The analyte followed a linear pattern over the concentration range of 1.0-14.0 μg/mL, with a lower detection limit of 0.21 μg/mL and a quantitation limit of 0.64 μg/mL. The suggested method was completely validated according to the International Conference on Harmonization (ICH) guidelines regarding linearity, accuracy, precision, specificity, and robustness, which permits its application for the intended purpose.

Research topics

  • Antibiotics Pharmacokinetics and Efficacy
  • Pharmaceutical and Antibiotic Environmental Impacts
  • Analytical Methods in Pharmaceuticals

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.21608/rpbs.2024.299538.1304

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.